Infection control measures in intensive care units - PowerPoint PPT Presentation

1 / 39
About This Presentation
Title:

Infection control measures in intensive care units

Description:

PRE-PREGNANCY COUNSELING Hemoglobinopathies Antenatal screening is routinely offered to all women in areas where 15% of the population are in high risk ethnic groups ... – PowerPoint PPT presentation

Number of Views:431
Avg rating:3.0/5.0
Slides: 40
Provided by: ESS67
Category:

less

Transcript and Presenter's Notes

Title: Infection control measures in intensive care units


1
PRE-PREGNANCY COUNSELING
2
Objectives
  1. Being able to council females before pregnancy.
  2. Identification of Risk factors in female before
    pregnancy.
  3. Being able to select high risk cases for further
    screening test.

3
  • The aim of pre-pregnancy care is to give a woman
    enough information for her pregnancy to occur
    under the optimal possible circumstances.

4
  • Areas to cover are

5
Diet
  • Folate rich foods prior to pregnancy and in the
    first l2 wk. of pregnancy .
  • Avoidance of un-pasteurized dairy products,
    uncooked eggs, pre-prepared salads to prevent
    infection (e.g. Listeriosis, salmonella) during
    pregnancy.

6
  • When preparing food keep cooked and raw meats
    separately.
  • Wash all soil off fruit and vegetables before
    eating.
  • Wash hands before and after preparation.
  • Only eat well-cooked meat.

7
Folate supplementation
  • If no previous neural tube defects,
  • folic acid 400 microgram supplementation prior to
    conception when pregnancy is being planned and
    for l3wk after conception
  • decreases risk of neural tube defect by 72.

8
Chronic disease
  • Review of pre-existing medical conditions with
    referral for expert advice where necessary.
  • Refer women who are diabetic for specialist
    diabetic review and change women taking oral
    hypo-glycemics to insulin.

9
  • Women with epilepsyreview medication. Heart
    diseaserefer for specialist advice if situation
    not clear.
  • GU disease (e.g. HIV, HSV, genital warts,
    bacterial vaginosis)refer for treatment advice
    on mode of delivery if necessary.
  • Discontinue all known possible teratogens prior
    to conception

10
Problems in previous pregnancies
  • Recurrent miscarriage
  • cervical incompetence
  • congenital abnormalities
  • inherited disorders
  • pre-pregnancy counseling and detailed advice on
    genetic screening for high-risk pregnancies is
    available via regional genetics services.

11
Rubella status
  • If rubella status is unknown suggest it is
    checked.
  • Rubella infection in early pregnancy carries a
    high chance (4070) of deafness, blindness,
    cardiac abnormalities or multiple fetal
    abnormalities.
  • If the woman is not rubella immune, suggest
    immunization with avoidance of pregnancy for 3
    months afterwards (live vaccine).

12
Contraception
  • Women contemplating pregnancy are usually still
    using contraception.
  • Discussion about how to stop/what to expect may
    be helpful (e.g. injectables, IUCD).

13
Smoking
  • Smoking decreases ovulation, sperm count sperm
    motility.
  • Once the woman is pregnant, smoking increases
    miscarriage rate two times
  • risk of pre-term delivery
  • and low birth weight (by an average of200g).
  • Explain risks and advise on ways to stop (this
    includes passive smoking).

14
Work benefits
  • Discussion of benefits available during pregnancy
    and employment law is necessary so that women
  • may avoid possible hazards at work,
  • attend for antenatal care and
  • plan their maternity leave from early in
    pregnancy.

15
Discussion of antenatal care and screening
available
  • Brief discussion of antenatal screening and
    antenatal care procedures
  • allows women to investigate their choices in
    pregnancy at their leisure.
  • Brief discussion about miscarriage and
    possibility of infertility
  • allows women to be more confident about asking
    for help if problems with conception/early
    pregnancy occur.

16
SCREENING IN PREGNANCY
  • Most women undergo some form of screening before
    or during pregnancy.
  • It aims to identify, prevent and treat actual or
    potential problems.
  • Women and their partners must be given unbiased
    information regarding screening and diagnostic
    tests, the meaning and consequences of both, what
    to expect in terms of results, and further
    options for management.

17
  • Family physicians need to be aware of the
    techniques of prenatal diagnosis in order to
  • Identify all women who might benefit from genetic
    counseling and/or early assessment by the
    obstetrician
  • Counsel patients about the accuracy and risk of
    prenatal diagnosis
  • Make sure that the opportunity for prenatal
    diagnosis is not overlooked as certain tests are
    done at certain times.

18
Pre-pregnancy genetic screening
  • There are many inherited diseases and more are
    being discovered all the time.
  • Refer before pregnancy couples who request
    referral or those with factors, which put them at
    high risk of having a baby with a genetic
    disorder to a trained obstetrician or genetic
    counselor.
  • Risk factors that warrant pre-pregnancy genetic
    screening

19
  • Personal or past history of genetic abnormality
  • e.g. Downs syndrome
  • sickle cell
  • other muscular dystrophies
  • Huntingtons chorea
  • polycystic kidneys.
  • Diabetic mothers
  • have an increased risk of feti with congenital
    anomalies.

20
  • Older women
  • Risk of Downs syndrome increases with maternal
    age.
  • Consanguineous couples
  • 1st degree cousins who have a baby together have
    an increased risk of congenital malformations in
    their offspring.

21
Tools of antenatal screening
  • After referral to the specialist, certain tools
    may be used for optimal counseling.
  • Basic screening tests
  • Blood e.g. Hb estimation and blood group
  • Urine dipstick screening of urine for proteinuria
    and glycosuria

22
  • rubella immune status screening
  • hepatitis B screening
  • syphilis screening.
  • Many women are not aware these tests have been
    done let alone their purpose or results. Ensure
    women are given information about the reasons
    for, significance of and results of routine
    tests.

23
  • Ultrasound scan
  • High resolution anomaly scan is routinely
    offered to pregnant women at 18 weeks of
    gestation.
  • Its purpose is to detect structural abnormalities
    e.g.
  • Cardiac,
  • GIT,
  • Skeletal abnormalities, etc.

24
a-fetoprotein (AFP)
  • measured in the maternal blood and amniotic
    fluid.
  • Its level increases with twins or fetal
    malformation (10)
  • neural tube defect,
  • exomphalos,
  • posterior urethral valves,
  • nephrosis,
  • or Turners syndrom

25
  • Decreased levels are associated with
  • diabetic mothers and
  • chromosomal abnormality e.g. Down syndrome.
  • Routinely offered in many centers.
  • AFP alone is a non-specific test requiring those
    with abnormal values to undergo further
    investigation.

26
  • Chorionic villi sampling (CVS)
  • At 10-L2wk gestation the developing placenta is
    sampled per abdomen or trans-cervically with US
    guidance.
  • Used to detect genetic or metabolic abnormality
    in high risk pregnancies.

27
  • Advantages.
  • Undertaken earlier than amniocentesis to allow
    termination of affected pregnancies at an earlier
    stage.
  • Risks.
  • 4 miscarrage,
  • limb defects (rare).

28
  • At Amniocentesis
  • Sampling of amniotic fluid via a transabominal
    needle under ultrasound guidance.
  • When undertaken for screening purposes,
  • it takes place from 16-l9wk gestation.
  • May be routinely offered to women
  • at high risk of fetal abnormality (e.g. women gt35
    years of age to exclude Downs syndrome)
  • or to clarify abnormalities found with other
    screening tests e.g. abnormal AFP.

29
Fetoscopy
  • Fibreoptic visualization of the fetus.
  • Carried out from l5wk.
  • Enables
  • external abnormalities to be detected,
  • fetal blood sampled and
  • organs biopsied.
  • Fetal loss rate 4.

30
For certain disorders, some standard tests are
offered
Spina bifida
  • U/S at 1719 wk gestation detects 9095 spina
    bifida and 100 anencephaly.
  • AFP detects 80 of open defects and 90 of those
    with anencephaly.
  • Confirmation with U/S in required.

31
Downs syndrome
  • The commonest single cause of mental handicap in
    children of school age. incidence 3/2000 births.
  • Numerous methods of antenatal screening have been
    tried but it is unclear which is best.
    Clarification is awaited.
  • Options are
  • Age Incidence with age1365 at age 35, rising
    to 1110 at age 40 and 130 at age 45.
  • Offering amniocentesis to all pregnant women gt35
    y combined with routine anomaly scanning
    identifies 70 of all cases of Downs syndrome.

32
  • AFP alonenon-specific test. Necessitates further
    evaluation in all cases.
  • Double/triple test Blood test which measures AFP
    and hCG estriol. Blood is taken at l6wk.
    gestation and a risk value calculated for the
    individual woman taking into account age, exact
    gestation and weight.
  • The result is expressed as a risk assessment
    (e.g. 1300) or as a ve or -ve result.
  • A ve result usually means the risk of having a
    Downs syndrome baby is gt1250 and amniocentesis
    is recommended.
  • A ve test does not indicate the presence of
    Downs syndrome but just an increased risk.

33
  • Nuchal translucency test U/S measurement of the
    translucency of the nuchal fold in the neck of
    the fetus at 10-l4wk. gestation. Detection rate
    80, false ve rate 8.
  • integrated test Combines blood tests and U/S to
    produce a single estimate of the womans risk of
    having a child with Downs syndrome.
  • Uses Womans age measurement at 10l3wk.
    gestation of nuchal translucency and maternal
    serum level of AFP, un-conjugated estriol, hCG.
  • Detection rate 85. Only 1 of women require
    unnecessary amniocentesis.

34
Hemoglobinopathies
  • Antenatal screening is routinely offered to all
    women in areas where gt15 of the population are
    in high risk ethnic groups
  • (Black ethnic groups for Sickle cell disease
  • and Mediterranean for thalathemias).

35
  • In other areas hemoglobinopathy screening should
    be offered to people whose racial background of
    hemoglobinopathies predominately occur.
  • Ideally screening should be carried out
    pre-conceptually.
  • Otherwise perform as early as possible into
    pregnancy.
  • All women identified as having a trait, or the
    disorder, should be referred for specialist
    counseling and their partners offered screening.

36
Pre-eclampsia
  • Risk factors
  • Age lt20y. or gt35y.
  • First pregnancy
  • Pre-eclampsia in a previous pregnancy or FH
  • Multiple pregnancy
  • Past history of increased BP
  • Renal disease
  • SLE

37
  • Diagnosis
  • BPgt 140/90 orgt 30/115 from booking BP
    proteinuria gt0.3g/24h.
  • Symptoms Headaches vomiting photophobia odd
    visual effects (flashing lights, stripes before
    the eyes, floaters or blackouts of vision)
    epigastric/ RUQ pain general malaise.
  • Examination General appearance (drowsy,
    confused) anemia jaundice non-dependent edema
    sudden weight gain neurological examination
    reflexes, fundi, clonus CVS examination lung
    bases abdominal examination RUQ or epigastric
    tenderness, palpable liver obstetric
    examination fundal height appropriate for
    gestational age liquor volume presentation
    fetal movements fetal heart sounds and heart
    rate urinedipstick for proteinuria (as litle as
    1 is significant).

38
  • Criteria for admission of patients with PET
  • BP gt has risen by gt30/2OmmHg over booking BP.
  • IUGR.
  • BP gt140/90 and symptomatic
  • BPgt 160/100
  • BP gt140/90 with proteinuria

39
Prevention
  • Low-dose aspirin is of benefit in women at risk
    of severe early pre-eclampsia i.e. those in whom
    it had occurred before.
  • Aspirin makes no difference to any other group
    treated.
  • Trials are in progress assessing .L-homocysteine
    in prevention of PET.
  • Other trials using fish oil, calcium and dietary
    protein supplementation have all proved
    inconclusive.
Write a Comment
User Comments (0)
About PowerShow.com